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DOI: 10.1039/c1jm11387aMagnetic resonance imaging (MRI) attracts great attention in
cellular and molecular imaging due to its non-invasive and multidi-
mensional tomographic capabilities. Development of new contrast
agents is necessary to enhance the MRI signal in tissues of interest.
Superparamagnetic iron oxide nanoparticles (SPIONs) are used as
contrast agents for signal enhancement as they have revealed
extraordinary magnetic properties at the nanometre size and their
toxicity level is very low compared to other commercial contrast
agents. In this study, we developed a new method to functionalize the
surface of SPIONs. Peptide amphiphile molecules are used to coat
SPIONs non-covalently to provide water solubility and to enhance
biocompatibility. Superparamagnetic properties of the peptide–
SPION complexes and their ability as contrast agents are demon-
strated. In vitro cell culture experiments reveal that the peptide–
SPION complexes are biocompatible and are localized around the
cells due to their peptide coating.Introduction
Magnetic resonance imaging (MRI) is one of the most powerful non-
invasive techniques for disease diagnosis. Due to its capability for
providing high spatial resolution non-invasively and revealing three-
dimensional anatomic details without any damage, it attracts intense
interest in clinical studies and became one of the most powerful
candidates for imaging techniques.1 MRI can measure the water
content of the tissue and excited nuclear spins of water molecules in
different tissues create distinct signal intensities that enable detection
of abnormal tissues.2 MRI uses radiofrequency in a magnetic field as
source of radiation which has no harmful effects on the body andaUNAM-Institute of Materials Science and Nanotechnology, Bilkent
University, Ankara, Turkey 06800. E-mail: moguler@unam.bilkent.edu.tr
bNational Magnetic Resonance Research Center (UMRAM), Bilkent
University, Ankara, Turkey 06800
cThe Scientific and Technical Research Council of Turkey (T €UB _ITAK),
National Metrology Institute (UME), Gebze, Kocaeli, Turkey 41470
dDepartment of Electrical and Electronics Engineering, Bilkent University,
Ankara, Turkey 06800
† Electronic supplementary information (ESI) available: The LC-MS
results of the PA molecules and additional nanoparticle
characterizations. See DOI: 10.1039/c1jm11387a
This journal is ª The Royal Society of Chemistry 2011measures the relaxivity (r1 or r2) of the water protons in the tissue at
a given magnetic field.3 In spite of these excellent features, develop-
ment of new contrast agents (CAs) is desired to enhance the precision
ofMRI. CAsmainly shorten theT1 orT2 relaxation times of protons
located in the proximity.4,5 Positive contrast agents reduce the
relaxation timeT1 which results in brighter contrast whereas negative
contrast agents reduce the relaxation time T2 which results in darker
contrast. There are numerous types of contrast agents on the market
and gadolinium (Gd3+) based CAs are the most widely used in MRI.
The most important drawback of the Gd3+ based CAs is their high
toxicity.4 Superparamagnetic iron oxide nanoparticles (SPIONs) are
good alternatives as CAs for MRI because of their low level of
toxicity, superparamagnetic properties and biocompatibility.6
Important parameters for SPIONs to be used as contrast agents
are their magnetic properties, surface coating properties and molec-
ular targeting potentials.7Themagnetic properties of the SPIONs are
controlled by their crystal structure, size and constituents.7,8 Thermal
decomposition enables the synthesis of monodisperse and crystalline
SPIONs.9 However, SPIONs produced by thermal decomposition
generally have hydrophobic molecules on their surface. Several
methods were developed tomake these nanoparticles water soluble in
order to enable their use in biological applications. Dextran and PEG
polymers were previously used to solubilize SPIONs in water.5
Dextran is a branched polysaccharide consisting of glucose subunits
and was used for surface coating of SPIONs because of its biocom-
patibility and high blood circulation time due to its neutral charge.10
PEG is a neutral linear polymer and can be preparedwith a variety of
terminal functional groups. Their neutral nature helps SPIONs to
escape from phagocytes providing a longer blood circulation time.
Although PEG and dextran increase blood circulation time of
SPIONs, they lack bioactivity. Previously, SPIONs were also func-
tionalized with folic acid for targeting purposes.11Although folic acid
offers better specificity and selectivity than PEG or dextran, it is still
not sufficient for accurate diagnosis since folic acid receptors are not
sufficient for targeting. Researchers have focused on using proteins
and peptides for targeted imaging and therapy for surface function-
alization of the SPIONs. In conventional methods, peptides are
conjugated to SPIONs covalently, however, peptide adsorption on
nanoparticles is very complex.12 In addition, protein and peptide
adsorption on nanoparticles is irreversible in covalent functionaliza-
tion and needs protecting groups to bind to proteins or peptides
selectively.13J. Mater. Chem., 2011, 21, 15157–15162 | 15157
Fig. 1 Non-covalent functionalization of SPIONs with peptide amphi-
phile molecules.
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View Article OnlineHerein, we demonstrate a new method to synthesize peptide
functionalized SPION CAs (Fig. 1). We exploited amphiphilic
peptide molecules as surfactants for the functionalization of SPIONs.
The hydrophobic segment of the peptide amphiphiles and SPIONs
interact non-covalently in aqueous conditions. Since the coating
process depends on hydrophobic interactions, peptide adsorption on
the nanoparticle surface is easier compared to covalent conjugation
approaches. Hydrophobic interactions prevent changes in crystal-
linity of the nanoparticles and allow non-covalent functionalization
to provide solubility in water. This technique provides opportunities
for incorporation of bioactive groups without any further function-
alization process.Experimental section
Materials
Dibenzyl ether was purchased from Merck, lauryl amine was
purchased from Sigma-Aldrich, iron 2,4-pentadionate (Fe(acac)3)
and lauric acid were purchased fromAlfa Aesar. 1,2-Hexadecanediol
was purchased from Sigma-Aldrich. 9-Fluorenylmethoxycarbonyl
(Fmoc) and tert-butoxycarbonyl (Boc) protected amino acids,
[4-[a-(20,40-dimethoxyphenyl)Fmoc-aminomethyl]phenoxy]acet-
amidonorleucyl-MBHA resin (Rink amide MBHA resin),
Fmoc-Asp(OtBu)-Wang resin and 2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU) were purchased
fromNovaBiochemandABCR.The other chemicals were purchased
from Fisher, Merck, Alfa Aesar or Aldrich and used as provided.Peptide amphiphile (PA) synthesis
Lauryl-VVAGK peptide (PA1) was constructed on MBHA Rink
amide resin and lauryl-VVAAD peptide (PA2) was constructed on
Fmoc-Asp-(OtBu)-OH preloadedWang resin. Amino acid couplings
were performed with 2 equivalents of Fmoc protected amino acid,
1.95 equivalents of HBTU and 3 equivalents of N,N-diisopropyle-
thylamine (DIEA) in DMF for 2 h. Fmoc deprotections were per-
formed with 20% piperidine/dimethylformamide (DMF) solution for
20 min. Cleavage of the peptides from the resin was carried out with
a mixture of trifluoroacetic acid (TFA) : triisoproplysilane (TIS) :
water in the ratio of 95 : 2.5 : 2.5 for 2 h. Excess TFA was removed
by rotary evaporation. The remaining viscous peptide solution was
treated with ice-cold diethyl ether and the resulting white pellet was
freeze-dried. The peptide amphiphiles were identified and analyzed by
reverse phase HPLC on an Agilent 6530 accurate-Mass Q-TOF15158 | J. Mater. Chem., 2011, 21, 15157–15162LC/MS equipped with an Agilent 1200 HPLC. An Agilent Zorbax
Extend-C18 2.1 50 mm column for basic conditions and a Zorbax
SB-C8 4.6 mm 100 mm column for acidic conditions were used to
analyze peptides. For PA1, the mobile phase was water/acetonitrile
gradient with 0.1% volume of formic acid. ForPA2, themobile phase
was water/acetonitrile gradient with 0.1% NH4OH. Chemical repre-
sentations of the peptides are demonstrated in Fig. S1.† Preparative
HPLC (Agilent 1200) was used for purification of the peptides. PA1
was purified by using a Zorbax prepHT 300CB-C8 column with
a water–acetonitrile (0.1% TFA) gradient. PA2 purification was
performed on a Zorbax Extend C-18 prep-HT with a water–aceto-
nitrile (0.1% NH4OH) gradient. The HPLC and mass spectrum of
PA1 are shown in Fig. S2–S3 and HPLC and mass spectrum of PA2
are presented in Fig. S4–S5.†
Superparamagnetic iron oxide nanoparticle synthesis
Magnetite (Fe3O4) nanoparticles were synthesized as previously
reported with slight modifications in the synthesis protocol.9 2 mmol
Fe(acac)3, 10 mmol 1,2-hexadecanediol, 6 mmol lauric acid and
6 mmol lauryl amine were dissolved in 20 ml of benzyl ether. The
solutionwas deoxygenated with nitrogen gas andmagnetically stirred
while heating up to 200 C for 2 h. Then, the solution was refluxed at
270 C for 1 h. It was cooled to room temperature and 50 ml ethanol
was added. The solution was centrifuged at 8000 rpm for 10 min.
Precipitated nanoparticles were collected and more ethanol was
added and centrifuged at 8000 rpm for 10 min. The nanoparticles
were dissolved in hexanes in the presence of 1 mmol lauric acid and
sonicated for 10 min. Then the solution was centrifuged at 8000 rpm
for 10 min. The magnetic properties of the samples were determined
at room temperature using the vibrating samplemagnetometer (LDJ,
Electronics Inc., Model 9600) with a maximum field of up to 15 kOe.
Non-covalent functionalization of superparamagnetic iron oxide
nanoparticles
30 mg of PA1was dissolved in 3 ml distilled water and the pH of the
solution was adjusted to pH 2. Then 10 mg ml1 SPION stock
solution in hexane was prepared. Peptide amphiphiles and SPIONs
were mixed with a weight ratio of 1 : 7. 35 mg/3.5 ml of peptide
amphiphile solutionwas then sonicated for 5min and 5mg/0.35ml of
SPION solution was poured into the PA solution. The mixture was
shaken for a couple of seconds and sonicated for 1min. This step was
repeated for 10 min and sonication was performed for 1 h at 60 C.
The solution was heated to 60 C and then sonicated for 1 h more at
60 C. The same process was repeated for PA2 at pH 11. Then, the
solution was filtered through a 1 mm PTFE filter and 1 ml
dichloromethane was poured into the solution which was then
shaken for a couple of seconds and centrifuged at 8000 rpm for 2min.
This step was repeated 3 times. Solutions were dialyzed with 500–
1000 Da cellulose dialysis membrane. A representative drawing of
noncovalent functionalization is shown in Fig. 1.
Dynamic light scattering
Hydrodynamic size and polydispersity index of the particles were
measured by dynamic light scattering (DLS). A Malvern Nanosizer/
Zetasizer nano-ZS ZEN 3600 (Malvern Instruments, USA) instru-
ment was used for DLS analysis. Hydrophobic particles were diluted
with hexane and measurements were performed in a quartz cuvette.This journal is ª The Royal Society of Chemistry 2011
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View Article OnlineThe hydrophilic particles were diluted with water and measurements
were performed in a polystyrene cuvette.
X-Ray diffraction (XRD)
A Panalytical X’PERT Pro MRD was used to perform XRD
diffraction pattern analysis under Cu-Ka radiation. A solution of
lauric acid coated magnetic nanoparticles was deposited on a glass
substrate and the solvent was evaporated off.
FT-IR
A Bruker VERTEX 70 with a Hyperion Scanning Microscope was
used for the FT-IR analysis. Hydrophobic nanoparticle solution was
dropped onto sodium chloride glass and air-dried. Transmittance
characterization was done between 370 and 4000 cm1.
Cell viability
Mouse embryonic fibroblast cells (NIH 3T3) were used to analyze the
effect of SPIONs on cell viability. NIH 3T3 cells were cultured in
DMEM supplemented with 10% calf serum. Cells were seeded in 96
well plates (5000 cells/well) and varying concentrations of SPIONs
(500 mg ml1, 200 mg ml1, 100 mg ml1, 50 mg ml1) were added 24 h
later at pH 7. Live/dead assay from Invitrogen was used to detect live
cells by Calcein AM (2 mM) and dead cells by ethidium homodimer 1
(2 mM) 48 h after the addition of SPIONs. Fluorescence measure-
ments were taken by a M5 microplate reader (Molecular Devices).
Peptides that are not coupled with iron oxide nanoparticles were used
as control at the same concentrations.
Prussian blue staining
To detect cell internalization and localization of SPIONs, cells were
stained with Prussian Blue (PB). NIH 3T3 cells were seeded in 96 wellFig. 2 a) Dichloromethane (DCM)–water phase image of lauric acid coated
phase image of PA1-SPION complex. d) TEM image of PA1-SPION compl
SPION. g) XRD pattern of lauric acid coated SPION, PA1-SPION and PA2
This journal is ª The Royal Society of Chemistry 2011plates 3000 cells/well) and 24 h after seeding cells, SPIONs were
added (500 mg ml1) at pH 7. 24 h after addition of SPIONs, PB
staining was performed. After washing wells with PBS several times,
cells were fixed with 4% paraformaldehyde. A fresh mixture of 2%
HCl + 2% K4Fe[CN]6 (1 : 1) was then added to the cells and incu-
bated at room temperature for 30 min. After washing with PBS
several times, images were taken under an inverted microscope
(Zeiss). The iron content was quantitatively determined by the
colorimetric PB assay andmeasured by a SpectramaxM5 (Molecular
Devices). Samples were prepared by mixing 200 ml of PA1-SPION,
PA2-SPION or their diluted solution with 200 ml of 6 N HCl for 1 h
at 60 C. The iron content of samples was calculated by comparing
the absorbance to that of a range of standard concentrations of equal
volume.Magnetic resonance imaging
MRI measurements of the peptide coated SPIONs were performed
on a Siemens 3T TIMTrio Scanner (Siemens Medical Solutions,
Erlangen,Germany). Peptide coated SPIONswere dispersed inwater
and diluted to various concentrations (0.0375, 0.075, 0.15, 0.2, 0.5
mM) and the pH of the solutions was adjusted to 7. A 5 ml glass
sample holder was placed in the iso-center of the magnet. Spin-echo
pulse sequences with multiple spin echoes of various echo times were
utilized to obtain pixel-by-pixel T1 and T2 maps of each sample. T1
and T2 relaxation times were measured from large regions of interest
and results were inverted to obtain the R1 and R2 relaxation rates in
s1. MR imaging capabilities of the SPIONs were examined at 3 T
with the following parameters: point resolution: 0.11–0.11 cm, section
thickness: 2.3mm,TE: 11, 13, 15, 18, 20, 30, 50, 100, 200, 500ms, TR:
3000 ms; another set of experiments were set up with the following
parameters: TR: 100, 200, 500, 1000, 2000, 5000 ms, TE:11 ms,
number of acquisitions: 3. As T2 and T1 weighted images were
obtained with various echo times, T2 and T1 values were calculatedSPIONs. b) TEM image of lauric acid coated SPION. c) DCM–water
ex. e) DCM–water phase image of PA2-SPION. f) TEM image of PA2-
-SPION.
J. Mater. Chem., 2011, 21, 15157–15162 | 15159
Table 1 Physicochemical properties of peptide–SPION complexes
SPION coating Size by TEM (nm)
Size by
DLS (nm)
Transversal relaxivity
(r2) (s
1 mM1) r2/r1
Saturation magnetization
(Ms) (emu g
1)
Lauric acid 7 nm 8–10 nm — — 53
PA1 24 nm 24–32 nm 100.4 111.55 8
PA2 30 nm 26–38 nm 93.7 55.1 5
Fig. 3 Contrast images of the peptide–SPION complexes measured at
TR¼ 3000 ms and TE¼ 50 ms (top). Relaxation rates (1/T2, s1) of PA1-
SPION and PA2-SPION as a function of iron concentration in water in
a magnetic field of 3 T at room temperature (bottom).
Fig. 4 Cell viability assay, 48 h after addition of SPIONs on NIH 3T3 cells re
with respect to uncoated SPIONS and no treatment.
15160 | J. Mater. Chem., 2011, 21, 15157–15162
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View Article Onlineusing the curve fitting toolbox of Matlab. The r1 and r2 values were
calculated based on 1/T2 and 1/T1 versus iron concentration deter-
mined with Prussian blue colorimetric assay.Results and discussion
SPIONs were synthesized by the thermal decomposition method
which produces uniform nanoparticles.9 We were able to synthesize
monodisperse nanoparticles with diameters of 6–7 nm without
aggregation (Fig. 2b). Lauric acid was used as a surfactant on the
SPIONs and the end products were stable in organic solvents
(Fig. 2a). Numerous efforts have been previously reported aiming to
coat these particles with hydrophilic molecules (silanization,14 poly-
mers,15 protein absorption,16 etc.). Recently, amphiphilic polymers
were used to transfer the SPIONs into aqueous solutions.15 Polymers
require a covalent attachment process to provide bioactivity and/or
biocompatibility. In this study, we developed a new method to
solubilize SPIONs in water by using peptide amphiphile (PA) mole-
cules. The hydrophobic part of the PAs is composed of lauric acid
which intercalates hydrophobically with lauric acid chains covering
the SPIONs (Fig. 1). The hydrophilic peptide segment of the PA
molecule is exposed at the exterior part of the SPIONs and provides
stability and bioactivity in aqueous conditions.17 The PAs can be
modified by various peptide sequences for targeting desired cell types
and/ormolecules. The optimum ratio for the synthesis of the peptide–
SPION complex was found to be 7 mg PA to 1 mg SPION and the
optimumvolume for themixture is 10ml PA solution inwater to 1ml
of SPIONs in hexane. Excess amount of PA was used with the
optimum dilution to prevent aggregation of SPIONs. The excess
amount of SPIONs was removed via filtration through a 0.20 mmvealed that treatment with peptide coated SPIONs enhanced cell viability
This journal is ª The Royal Society of Chemistry 2011
Fig. 5 NIH 3T3 cells stained by Prussian blue reaction after 24 h
treatment. a) PA1-SPION, b) PA2-SPION, c) negative control. Positively
charged SPIONs are bound to the cell surface more than negatively
charged or uncoated SPIONs because of the negatively charged nature of
the cell surface.
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View Article Onlinefilter and centrifugation. Afterwards, the solutions were dialyzed with
500–1000 Dalton cellulose membrane bags to remove excess PAs.
The hysteresis loop of the SPIONs was measured by VSM to study
superparamagnetic behavior at room temperature. As shown in
Fig. S7,† the SPIONs have zero coercivity field and do not reach
saturation at high fields indicating that these nanoparticles are
superparamagnetic. Fig. S7 also shows the magnetization curves of
synthesized SPIONs before and after functionalization processes. The
saturation magnetization (Ms) of a lauric acid stabilized SPION
sample was found to be 56 emu g1. After functionalization process,
Ms of PA1-SPION decreased to 5 emu g
1 and Ms of PA2-SPION
decreased to 8 emu g1. The decrease inMs value was caused by the
peptide coating.18
TEM characterization of SPIONs revealed a narrow size distri-
bution even with the PA coating (about 25–40 nm in diameter)
(Table 1, Fig. 2 and Fig. S6). XRD pattern shown in Fig. 2g
demonstrates that SPIONs were synthesized in magnetite form
without any changes in their crystallinity. In Fig. 2 a, c and e, the
effects of surface coating on the solubility of the SPIONs are
demonstrated. The lauric acid coated SPIONs were stable in
dichloromethane solution. After surface coating, the SPIONs were
successfully transferred into aqueous solution. The FT-IR spectrum
in Fig. S9† revealed amine and amide peaks due to the presence of
peptide on the SPIONs.
Hydrophobic encapsulation of SPIONs by PAs changes the size of
the particles. The TEM images of the SPIONs reveal that the
nanoparticle size is around 8–10 nm in diameter (Table 1 and Fig. 2).
Peptide coated nanoparticles were imaged by TEM directly (Fig. 2)
and by staining with uranyl acetate and phosphotungstic acid to
observe the effect of the peptide segment. The sizes of the peptide
coated nanoparticles were increased significantly. In addition, the
hydrodynamic size of the peptide coated SPIONs was also measured
by the DLS technique. The increase in size upon encapsulation was
also observed in DLS (Table 1). The size increase can be explained by
the nonspecific aggregation of the PA molecules. The amount of PA
molecules may be more than the amount needed to solubilize the
nanoparticles because of the aggregation tendency of the PA
molecules.
SPIONs are negative contrast agents and reduce the T2 relaxation
time of water protons resulting in darker signals. Relaxation rates R1
and R2, which are the reciprocals of the relaxation times, reveal the
relaxivity values r1 and r2 of SPIONs depending on the total metal
concentration. These values determine the effectiveness of the
SPIONs as a contrast agent. The relaxivity values are investigated
under 3 T magnetic field and the r1 and r2 relaxivity values of PA1-
SPION are 0.9 mM1 s1 and 100.4 mM1 s1, whereas r1 and r2
values of PA2-SPION are 1.8 mM1 s1 and 93.7 mM1 s1 respec-
tively in water as shown in Table 1 and Fig. 3. It is known that the
r2/r1 ratio is an important parameter to determine the T2 contrast
agent efficiency. The r2/r1 ratio forPA1-SPION is 111.55 and it is 52.1
for PA2-SPION. The r2 relaxivity values observed here are close to
those of commercial SPIONs and their particle size is much smaller,
whereas the r2/r1 ratio is much greater than the commercial ones.
19–22
The biocompatibility of the peptide coated nanoparticles was
tested by culturing NIH 3T3 cells. The number of viable cells incu-
bated with peptide–SPION complex was increased up to 170%
compared to cells not treated with peptide–SPION (Fig. 4). These
results revealed that peptide–SPION complexes are highly biocom-
patible. The increase in cell viability is due to peptide coatings whichThis journal is ª The Royal Society of Chemistry 2011provide mechanical support for cells, similar to the natural extracel-
lular matrix. In order to test this, the cell viability test was repeated
with cells treated with PAmolecules without magnetic nanoparticles.
Results indicated that PA molecules caused the increase in cell
viability (Fig. S8†). We also carried out Prussian blue staining to
observe where these nanoparticles were located in the cells. Staining
was carried out 24 h after addition of peptide–SPION complex to the
cells. Positively chargedPA1-SPIONs were observed to be located on
the cell membrane ormatrix whereas negatively chargedPA2-SPION
complexes could not bind to cells and were removed from the
medium in the PBS washing step (Fig. 5). The positively charged
molecules are attracted to the cell membrane because of the negative
charge of the cell surface.
By using peptide amphiphile molecules, we developed water
soluble and biocompatible SPIONs as MRI contrast agents. PeptideJ. Mater. Chem., 2011, 21, 15157–15162 | 15161
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View Article Onlineamphiphile molecules provided stability in aqueous solutions, bio-
functionality through their peptide sequence and enhanced physico-
chemical properties for SPIONs. Their ability to be used as MRI
contrast agents is demonstrated in Table 1. Peptide synthesis enables
control over peptide sequences23 for specific and selective localization
of nanoparticles to target cells. By using homing peptide sequences,24
it is possible to target organs such as brain,25 kidney,25 heart,26 breast24
and several tumor tissues.27,28Thus, by using non-covalent function-
alization of SPIONs with appropriate peptide sequences, cellular or
molecular targeting is possible without any further coupling process.Conclusion
This study presents a novel method for coating SPIONs based on
intercalation of PA molecules with SPIONs by hydrophobic inter-
actions. The hydrophobic encapsulation of SPIONs by PAmolecules
provided solubility in water and enabled us to overcome problems
associated with surfactant exchange for SPION coating. In vitro cell
culture experiments revealed that the peptide–SPION complex is
a biocompatible system. Their use as MRI contrast agents is also
demonstrated. MR active system shown here can be selectively
functionalized by using various peptide molecules for targeting
specific tissues. Potential applications of these materials for tissue
engineering, biological separation and biosensor applications are
under investigation.Acknowledgements
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